Raymond James Initiates Coverage On Omega Therapeutics with Outperform Rating, Announces Price Target of $12
Portfolio Pulse from Benzinga Newsdesk
Raymond James has initiated coverage on Omega Therapeutics (NASDAQ:OMGA) with an Outperform rating and a price target of $12.
June 18, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James has initiated coverage on Omega Therapeutics with an Outperform rating and a price target of $12.
The initiation of coverage with an Outperform rating and a specific price target of $12 by a reputable analyst from Raymond James is likely to positively influence investor sentiment and drive short-term price appreciation for Omega Therapeutics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100